Kopran Ltd (KOPRAN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 568367,
    "name": "Kopran",
    "stock_name": "Kopran",
    "full_name": "Kopran Ltd",
    "name_url": "stocks-analysis/kopran",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "149.00",
    "chg": -3.95,
    "chgp": "-2.58%",
    "dir": -1,
    "prev_price": "152.95",
    "mcapval": "747.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524280,
    "symbol": "KOPRAN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE082A01010",
    "curr_date": "Dec 24",
    "curr_time": "",
    "bse_nse_vol": "23.02 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 24, 2025",
    "traded_date_str": "2025 12 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kopran-568367-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kopran Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3759664",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_mojoScore_3759664.png",
        "date": "2025-12-16 08:36:15",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and shifting technical indicators. Recent assessment changes reflect a cautious stance as the company contends with persistent sales declines, negative profitability trends, and bearish technical momentum, all set against a backdrop of broader market performance."
      },
      {
        "title": "Kopran Technical Momentum Shifts Amidst Bearish Indicators and Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-technical-momentum-shifts-amid-bearish-signals-market-performance-lags-sensex-3755933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_technicaldot_3755933.png",
        "date": "2025-12-11 08:07:51",
        "description": "Kopran, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a notable shift in its technical momentum. Recent market data reveals a transition towards bearish trends across multiple timeframes, with key indicators such as MACD, RSI, and moving averages signalling a complex interplay of market forces impacting the stock’s price trajectory."
      },
      {
        "title": "Kopran Stock Analysis: Evaluation Metrics Reflect Mixed Signals Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-stock-rating-upgraded-to-sell-amid-mixed-technicals-and-weak-financials-3754858",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_mojoScore_3754858.png",
        "date": "2025-12-10 08:18:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in market assessment driven by a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent price movements, the company’s financial performance continues to present challenges, prompting a nuanced revision in its overall evaluation."
      },
      {
        "title": "Kopran Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-technical-momentum-shifts-amid-mixed-indicator-signals-3754676",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_technicaldot_3754676.png",
        "date": "2025-12-10 08:06:43",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across key indicators. Recent price movements and technical assessments reveal a transition from a predominantly bearish stance to a more mildly bearish outlook, underscoring evolving market dynamics for the stock."
      },
      {
        "title": "Kopran’s Evaluation Revised Amidst Challenging Financial and Technical Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kopran-downgraded-to-strong-sell-by-marketsmojo-amid-weak-financials-and-bearish-technicals-3746328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Kopran_mojoScore_3746328.png",
        "date": "2025-12-04 11:08:46",
        "description": "Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial performance and technical outlook. This adjustment follows a series of results that have highlighted persistent operational difficulties and subdued investor interest."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724752.png",
        "date": "2025-11-24 10:42:33",
        "description": "Kopran, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724749.png",
        "date": "2025-11-24 10:42:30",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724763.png",
        "date": "2025-11-24 10:42:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning."
      },
      {
        "title": "Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kopran-stock-falls-to-52-week-low-of-rs1266-amid-continued-weak-performance-3724750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Kopran_priceRelatedfactors_3724750.png",
        "date": "2025-11-24 10:42:23",
        "description": "Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices."
      }
    ],
    "total": 255,
    "sid": "568367",
    "stock_news_url": "https://www.marketsmojo.com/news/kopran-568367"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Dec-2025",
      "details": "Results for the third quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Dec-2025",
      "details": "Results for the Quarter ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "12-Nov-2025",
      "details": "Investor Presentation on Q2 FY 2025-26 results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kopran Ltd has declared <strong>30%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kopran Faces Challenging Market Conditions Amid Mixed Financial and Technical Signals

2025-12-16 08:36:15

Kopran, a player in the Pharmaceuticals & Biotechnology sector, is currently navigating a complex market environment marked by subdued financial results and shifting technical indicators. Recent assessment changes reflect a cautious stance as the company contends with persistent sales declines, negative profitability trends, and bearish technical momentum, all set against a backdrop of broader market performance.

Kopran Technical Momentum Shifts Amidst Bearish Indicators and Market Pressure

2025-12-11 08:07:51

Kopran, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a notable shift in its technical momentum. Recent market data reveals a transition towards bearish trends across multiple timeframes, with key indicators such as MACD, RSI, and moving averages signalling a complex interplay of market forces impacting the stock’s price trajectory.

Kopran Stock Analysis: Evaluation Metrics Reflect Mixed Signals Amidst Challenging Financials

2025-12-10 08:18:23

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has experienced a shift in market assessment driven by a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent price movements, the company’s financial performance continues to present challenges, prompting a nuanced revision in its overall evaluation.

Kopran Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-10 08:06:43

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across key indicators. Recent price movements and technical assessments reveal a transition from a predominantly bearish stance to a more mildly bearish outlook, underscoring evolving market dynamics for the stock.

Kopran’s Evaluation Revised Amidst Challenging Financial and Technical Trends

2025-12-04 11:08:46

Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting ongoing challenges in its financial performance and technical outlook. This adjustment follows a series of results that have highlighted persistent operational difficulties and subdued investor interest.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:33

Kopran, a company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low price of Rs.126.6, marking a significant decline amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance over recent quarters.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:30

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amidst Continued Downtrend

2025-11-24 10:42:23

Kopran, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.126.6 today, marking a significant milestone in its ongoing decline. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and market positioning.

Kopran Stock Falls to 52-Week Low of Rs.126.6 Amid Continued Downtrend

2025-11-24 10:42:23

View All News